LEGN
Legend Biotech Corp
Next earnings Aug 10, 2026 (before open) · consensus $0.09 EPS, $370M rev
$29.91
▲ +1.77%$29.91▼ -13.63%
over 1Y
L $16.65H $44.32
Today+1.8%
1W+5.2%
1M-17.6%
3M+56.3%
YTD+39.1%
1Y-13.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 23 analysts
Buy
Mixed signals in the latest filings.
Legend Biotech Corp shows limited reported revenue.
On these fundamentals, LEGN screens as SELL on the SEC figures.
Is LEGN a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread~60d expiry
- Long put 30 @ ~6.07 est
- Short put 27 @ ~4.40 est
debit $167max +$133max −$167BE 28.33
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
No income data filed.
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$5.79B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.7%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗144Filing2026-06-30open ↗4Period ending 2026-06-252026-06-29open ↗144Filing2026-06-26open ↗6-KPeriod ending 2026-06-222026-06-22open ↗424B5Filing2026-06-18open ↗424B5Filing2026-06-17open ↗F-6EFFiling2026-06-17open ↗6-KPeriod ending 2026-06-152026-06-15open ↗6-KPeriod ending 2026-06-022026-06-02open ↗6-KPeriod ending 2026-06-012026-06-01open ↗
Frequently asked
- Is Legend Biotech Corp (LEGN) a buy?
- LEGN currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is Legend Biotech Corp's quality score?
- LEGN scores 55.314665270080845/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001801198, latest 4 filed 2026-07-02) · EODHD · as of 6/20/2026, 7:25:08 AM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 20, 2026, 3:25 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.